FibroGen Inc (NAS:FGEN)
$ 1.18 -0.03 (-2.48%) Market Cap: 117.38 Mil Enterprise Value: 92.72 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 58/100

FibroGen Inc at Leerink Global Healthcare Conference Transcript

Feb 25, 2020 / 08:30PM GMT
Release Date Price: $42.96 (-1.45%)
Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research, MD & Senior Biotechnology Analyst

Relatively recently appointed CEO, Enrique Conterno, and other members of the FibroGen team. Hi, Peony. So welcome to GHC this year.

Enrique A. Conterno
FibroGen, Inc. - CEO & Director

Thank you, Geoff.

Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research, MD & Senior Biotechnology Analyst

Your first GHC, how is it going?

Enrique A. Conterno
FibroGen, Inc. - CEO & Director

I think it's going awesome. We had a packed agenda today, met with a number of investors. Very good.

Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research, MD & Senior Biotechnology Analyst

Good.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot